Epilepsy Research

Epilepsy is a group of neurological conditions consisting of recurrent, usually unprovoked epileptic seizures. Epileptic seizures have recently been defined as "a transient occurrence of signs and/or symptoms due to abnormal, excessive or synchronous neuronal activity in the brain". Epilepsy is one of the most common disorders of the brain, with one in 10 people suffering at least one seizure in their lifetime. There are over 40 different types of epilepsy, each of which presents with its own unique combination of seizure type, typical age of onset, EEG findings, treatment, and prognosis.

Epilepsy Research Products Targets

Products for Epilepsy Research - Page 42

  1. Cat.No. Product Name Information/Activity
  2. BCC6156 MNI 137 946619-21-2 MNI 137 chemical structure
  3. BCC7866 Xanthurenic acid Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Xanthurenic acid chemical structure
  4. BCC1487 Clozapine N-oxide (CNO) Activator of muscarinic DREAADs,Clozapine N-oxide is a pharmacologically inert metabolite of Clozapine, which is a potent <b>5-HT1C</b> receptor antagonist. Clozapine N-oxide (CNO) chemical structure
  5. BCC5702 ACPT-I 194918-76-8 ACPT-I chemical structure
  6. BCC7344 AMN 082 dihydrochloride The first selective mGlu<sub>7</sub> agonist AMN 082 dihydrochloride chemical structure
  7. BCC6550 L-AP4 L-APB is a potent and specific agonist for the group III mGluRs, with EC50s of 0.13, 0.29, 1.0, 249 μM for mGlu4, mGlu8, mGlu6 and mGlu7 receptors, respectively. L-AP4 chemical structure
  8. BCC7865 Cinnabarinic acid 606-59-7 Cinnabarinic acid chemical structure
  9. BCC7045 (RS)-3,4-DCPG 176796-64-8 (RS)-3,4-DCPG chemical structure
  10. BCC7012 (S)-3,4-DCPG 201730-11-2 (S)-3,4-DCPG chemical structure
  11. BCC7652 NPEC-caged-(S)-3,4-DCPG 1257323-85-5 NPEC-caged-(S)-3,4-DCPG chemical structure

Items 411 to 420 of 560 total